Correction: PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2191-219X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Correction: PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer ; volume:13 ; number:1 ; day:10 ; month:2 ; year:2023 ; pages:1 ; date:12.2023
EJNMMI Research ; 13, Heft 1 (10.2.2023), 1, 12.2023
- Creator
-
Sankaranarayanan, Ramya Ambur
Florea, Alexandru
Allekotte, Susanne
Vogg, Andreas T. J.
Maurer, Jochen
Schäfer, Laura
Bolm, Carsten
Terhorst, Steven
Classen, Arno
Bauwens, Matthias
Morgenroth, Agnieszka
Mottaghy, Felix
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13550-023-00961-y
- URN
-
urn:nbn:de:101:1-2023041421233431690733
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sankaranarayanan, Ramya Ambur
- Florea, Alexandru
- Allekotte, Susanne
- Vogg, Andreas T. J.
- Maurer, Jochen
- Schäfer, Laura
- Bolm, Carsten
- Terhorst, Steven
- Classen, Arno
- Bauwens, Matthias
- Morgenroth, Agnieszka
- Mottaghy, Felix
- SpringerLink (Online service)
Other Objects (12)
Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study
PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer
PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer
Correction : PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer
Correction: Sankaranarayanan et al. Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study. Cancers 2022, 14, 230
Auger emitter based endogenous therapy with an Olaparib derivative in triple negative breast cancer
Multimodale Studien zum Arbeitsgedächtnis : Kombination von Positronenemissionstomographie (PET) und transkranieller Magnetstimulation (TMS)
Einfluß der fokalen transkraniellen Magnetstimulation auf die Bild-Benennlatenz bei Gesunden
Chirale Katalysatoren für enantioselektive C-C-Verknüpfungen
Entwicklung der Synthesen von N-Heterozyklen, Sulfonimidamiden und einem [$^125}I$]-markierten PARP-Inhibitor
Activating unreactive substrates : the role of secondary interactions
Eine Lösung ohne Lösung : Mechanochemie ermöglicht neue Anwendungsgebiete und Materialien
Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study
PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer
PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer
Correction : PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer
Correction: Sankaranarayanan et al. Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study. Cancers 2022, 14, 230
Auger emitter based endogenous therapy with an Olaparib derivative in triple negative breast cancer
Multimodale Studien zum Arbeitsgedächtnis : Kombination von Positronenemissionstomographie (PET) und transkranieller Magnetstimulation (TMS)
Einfluß der fokalen transkraniellen Magnetstimulation auf die Bild-Benennlatenz bei Gesunden
Chirale Katalysatoren für enantioselektive C-C-Verknüpfungen
Entwicklung der Synthesen von N-Heterozyklen, Sulfonimidamiden und einem [$^125}I$]-markierten PARP-Inhibitor
Activating unreactive substrates : the role of secondary interactions
Eine Lösung ohne Lösung : Mechanochemie ermöglicht neue Anwendungsgebiete und Materialien
Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study
PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer
PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer
Correction : PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer
Correction: Sankaranarayanan et al. Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study. Cancers 2022, 14, 230
Auger emitter based endogenous therapy with an Olaparib derivative in triple negative breast cancer
Multimodale Studien zum Arbeitsgedächtnis : Kombination von Positronenemissionstomographie (PET) und transkranieller Magnetstimulation (TMS)
Einfluß der fokalen transkraniellen Magnetstimulation auf die Bild-Benennlatenz bei Gesunden
Chirale Katalysatoren für enantioselektive C-C-Verknüpfungen
Entwicklung der Synthesen von N-Heterozyklen, Sulfonimidamiden und einem [$^125}I$]-markierten PARP-Inhibitor
Activating unreactive substrates : the role of secondary interactions